BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 19885536)

  • 1. Novel 1D chain Fe(III)-salen-like complexes involving anionic heterocyclic N-donor ligands. Synthesis, X-ray structure, magnetic, (57)Fe Mössbauer, and biological activity studies.
    Herchel R; Sindelár Z; Trávnícek Z; Zboril R; Vanco J
    Dalton Trans; 2009 Nov; (44):9870-80. PubMed ID: 19885536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exchange interactions and zero-field splittings in C3-symmetric Mn(III)6Fe(III): using molecular recognition for the construction of a series of high spin complexes based on the triplesalen ligand.
    Glaser T; Heidemeier M; Krickemeyer E; Bögge H; Stammler A; Fröhlich R; Bill E; Schnack J
    Inorg Chem; 2009 Jan; 48(2):607-20. PubMed ID: 19072685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel iron complexes bearing N6-substituted adenosine derivatives: synthesis, magnetic, 57Fe Mössbauer, DFT, and in vitro cytotoxicity studies.
    Trávnícek Z; Mikulík J; Cajan M; Zboril R; Popa I
    Bioorg Med Chem; 2008 Sep; 16(18):8719-28. PubMed ID: 18723360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first iron(III) complexes with cyclin-dependent kinase inhibitors: Magnetic, spectroscopic (IR, ES+ MS, NMR, (57)Fe Mössbauer), theoretical, and biological activity studies.
    Trávnícek Z; Popa I; Cajan M; Zboril R; Krystof V; Mikulík J
    J Inorg Biochem; 2010 Apr; 104(4):405-17. PubMed ID: 20056279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatility in the binding of 2-pyrazinecarboxylate with iron. Synthesis, structure and magnetic properties of iron(II) and iron(III) complexes.
    Tanase S; Marqués Gallego P; Bouwman E; Long GJ; Rebbouh L; Grandjean F; de Gelder R; Mutikainen I; Turpeinen U; Reedijk J
    Dalton Trans; 2006 Apr; (13):1675-84. PubMed ID: 16547543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of in vitro cytotoxicity of one-dimensional chain [Fe(salen)(L)](n) complexes against human cancer cell lines.
    Dvořák Z; Starha P; Sindelář Z; Trávníček Z
    Toxicol In Vitro; 2012 Apr; 26(3):480-4. PubMed ID: 22274660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structural and Mössbauer study of complexes with Fe(2)(micro-O(H))(2) cores: stepwise oxidation from Fe(II)(micro-OH)(2)Fe(II) through Fe(II)(micro-OH)(2)Fe(III) to Fe(III)(micro-O)(micro-OH)Fe(III).
    Stubna A; Jo DH; Costas M; Brenessel WW; Andres H; Bominaar EL; Münck E; Que L
    Inorg Chem; 2004 May; 43(10):3067-79. PubMed ID: 15132612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron(III) complexes of fluorescent hydroxamate ligands: preparation, properties, and cellular processing.
    Clarke AJ; Yamamoto N; Jensen P; Hambley TW
    Dalton Trans; 2009 Dec; (48):10787-98. PubMed ID: 20023908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design and assembly of a new series of cyanide-bridged Fe(III)-Mn(II) one-dimensional single chain complexes: synthesis, crystal structures, and magnetic properties.
    Zhang D; Wang H; Chen Y; Ni ZH; Tian L; Jiang J
    Inorg Chem; 2009 Jun; 48(12):5488-96. PubMed ID: 19441825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2:2 Fe(III):ligand and "adamantane core" 4:2 Fe(III):ligand (hydr)oxo complexes of an acyclic ditopic ligand.
    Ghiladi M; Larsen FB; McKenzie CJ; Sotofte I; Tuchagues JP
    Dalton Trans; 2005 May; (9):1687-92. PubMed ID: 15852119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantiopure tetranuclear iron(III) complexes using chiral reduced Schiff base ligands: synthesis, structure, spectroscopy, magnetic properties, and DFT studies.
    Singh R; Banerjee A; Colacio E; Rajak KK
    Inorg Chem; 2009 Jun; 48(11):4753-62. PubMed ID: 19466801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-dimensional iron(II) carboxylate linear chain polymer that exhibits a metamagnetic spin-canted antiferromagnetic to single-chain magnetic transition.
    Zheng YZ; Xue W; Tong ML; Chen XM; Grandjean F; Long GJ
    Inorg Chem; 2008 May; 47(10):4077-87. PubMed ID: 18422310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure, spectra and reactivity of iron(III) complexes of imidazole and pyrazole containing ligands as functional models for catechol dioxygenases.
    Dhanalakshmi T; Suresh E; Palaniandavar M
    Dalton Trans; 2009 Oct; (39):8317-28. PubMed ID: 19789784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands.
    Starha P; Trávnícek Z; Popa I
    J Inorg Biochem; 2009 Jul; 103(7):978-88. PubMed ID: 19457557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinuclear Fe(III) complexes with polydentate ligands of the family of dicarboxyimidazoles: nuclearity- and topology-controlled syntheses and Magneto-structural correlations.
    Angaridis P; Kampf JW; Pecoraro VL
    Inorg Chem; 2005 May; 44(10):3626-35. PubMed ID: 15877447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron(III) complexes of tridentate 3N ligands as functional models for catechol dioxygenases: the role of ligand N-alkyl substitution and solvent on reaction rate and product selectivity.
    Visvaganesan K; Mayilmurugan R; Suresh E; Palaniandavar M
    Inorg Chem; 2007 Nov; 46(24):10294-306. PubMed ID: 17958355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spin-frustrated complex, [Fe(II)Fe(III)(trans-1,4-cyclohexanedicarboxylate)1.5]infinity: interplay between single-chain magnetic behavior and magnetic ordering.
    Zheng YZ; Xue W; Zhang WX; Tong ML; Chen XM; Grandjean F; Long GJ; Ng SW; Panissod P; Drillon M
    Inorg Chem; 2009 Mar; 48(5):2028-42. PubMed ID: 19235964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase.
    Kowol CR; Berger R; Eichinger R; Roller A; Jakupec MA; Schmidt PP; Arion VB; Keppler BK
    J Med Chem; 2007 Mar; 50(6):1254-65. PubMed ID: 17315858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron(III) complexes of sterically hindered tetradentate monophenolate ligands as functional models for catechol 1,2-dioxygenases: the role of ligand stereoelectronic properties.
    Velusamy M; Mayilmurugan R; Palaniandavar M
    Inorg Chem; 2004 Oct; 43(20):6284-93. PubMed ID: 15446874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure, spectra and reactivity of iron(III) complexes of facially coordinating and sterically hindering 3N ligands as models for catechol dioxygenases.
    Sundaravel K; Dhanalakshmi T; Suresh E; Palaniandavar M
    Dalton Trans; 2008 Dec; (48):7012-25. PubMed ID: 19050788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.